PG545 enhances anti-cancer activity of chemotherapy in ovarian models and increases surrogate biomarkers such as VEGF in preclinical and clinical plasma samples

Lignende værker

• Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer
  af: Hoffmann, Robert, et al.
  Udgivet: (2020)
• A Phase I study of the novel immunomodulatory agent PG545 (pixatimod) in subjects with advanced solid tumours
  af: Dredge, Keith, et al.
  Udgivet: (2018)
• Mechanisms of heparanase inhibition by the heparan sulfate mimetic PG545 and three structural analogues()
  af: Hammond, Edward, et al.
  Udgivet: (2013)
• The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
  af: Jung, Deok-Beom, et al.
  Udgivet: (2014)
• Correction: The heparan sulfate mimetic PG545 interferes with Wnt/β-catenin signaling and significantly suppresses pancreatic tumorigenesis alone and in combination with gemcitabine
  af: Jung, Deok-Beom, et al.
  Udgivet: (2019)